SCHEMBL18155029

SCHEMBL18155029

O=c1[nH]cc(-c2cccc(CO)c2)cc1-c1nc2cc(N3CCNCC3)ccc2[nH]1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFB2 P61812 1/20 0.87
PARP1 P09874 3/20 0.40
PIM1 P11309 5/20 0.38
PIM3 Q86V86 5/20 0.38
PIM2 Q9P1W9 2/20 0.38
MGLL Q99685 1/20 0.38
HTR1A P08908 2/20 0.36
HTR7 P34969 2/20 0.36
CDK1 P06493 1/20 0.36
CDK2 P24941 1/20 0.36
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
PRMT5 O14744 1/20 0.36
GRK6 P43250 1/20 0.35
CALML3 P27482 1/20 0.35
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
PIK3CG P48736 1/20 0.35
LRRK2 Q5S007 1/20 0.34
PDGFRB P09619 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL18155058 0.99 TGFB2 (0.85) TGFB2PARP1PIM1PIM3PIM2
SCHEMBL18155108 0.97 TGFB2 (0.81) TGFB2PARP1PIM1PIM3PIM2
SCHEMBL18155032 0.91 TGFB2 (0.72) TGFB2PARP1PIM1PIM3PIM2
SCHEMBL20048525 0.90 TGFB2 (0.71) TGFB2PARP1MGLLCALML3LRRK2
SCHEMBL18164072 0.90 TGFB2 (0.71) TGFB2PIM2LRRK2PDGFRBFGFR1
SCHEMBL18155035 0.90 TGFB2 (0.74) TGFB2PIK3CAMTORPIK3CGLRRK2
SCHEMBL18155062 0.90 TGFB2 (0.71) TGFB2PIM1PIM3PIM2HTR1A
SCHEMBL18155081 0.90 TGFB2 (0.70) TGFB2PARP1PIM1PIM3MGLL
Hydrochloric Acid SCHEMBL21456789 0.89 TGFB2 (0.69) TGFB2PARP1PIM1PIM3MGLL
SCHEMBL18155044 0.87 TGFB2 (0.67) TGFB2PDGFRBFGFR1KDRBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283475-B1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-10-16 EP claimed
EP-3283475-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES Merck Patent GmbH (DE) 2018-02-21 EP claimed
WO-2016165808-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2016-10-20 WO claimed
EP-3283475-B1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-10-16 EP disclosed
US-10179777-B2 3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives MERCK PATENT GMBH (DE) 2019-01-15 US disclosed
US-20180099947-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2018-04-12 US disclosed
WO-2016165808-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10179777-B2 3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives ALK, ABL2, ACVR1 TGFB2 267/4885PARP1 518/4885PIM1 68/4885
US-20180099947-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES ALK, ABL2, ACVR1 TGFB2 267/4885PARP1 518/4885PIM1 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.